TC
PFE icon

TAP Consulting’s Pfizer PFE Stock Holding History

TAP Consulting’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,734
Closed -$253K – 158
2024
Q3 		$253K Buy
8,734
+230
+3% +$6.71K 0.05% 141
2024
Q2 		$238K Buy
8,504
+372
+5% +$10.2K 0.05% 148
2024
Q1 		$226K Sell
8,132
-252
-3% -$6.99K 0.05% 145
2023
Q4 		$241K Buy
8,384
+100
+1% +$3.02K 0.06% 119
2023
Q3 		$275K Sell
8,284
-7,152
-46% -$253K 0.07% 118
2023
Q2 		$566K Sell
15,436
-569
-4% -$22.1K 0.14% 104
2023
Q1 		$653K Sell
16,005
-907
-5% -$39.2K 0.16% 94
2022
Q4 		$867K Buy
16,912
+69
+0.4% +$3.31K 0.23% 81
2022
Q3 		$737K Buy
16,843
+82
+0.5% +$3.98K 0.2% 79
2022
Q2 		$879K Sell
16,761
-317
-2% -$16.2K 0.24% 72
2022
Q1 		$884K Sell
17,078
-4,362
-20% -$226K 0.23% 77
2021
Q4 		$1.27M Buy
21,440
+783
+4% +$38.8K 0.29% 71
2021
Q3 		$888K Buy
20,657
+24
+0.1% +$1.06K 0.24% 84
2021
Q2 		$808K Buy
20,633
+246
+1% +$9.57K 0.23% 84
2021
Q1 		$739K Buy
20,387
+196
+1% +$6.96K 0.23% 83
2020
Q4 		$743K Buy
20,191
+3,171
+19% +$116K 0.27% 77
2020
Q3 		$593K Sell
17,020
-84
-0.5% -$2.94K 0.23% 80
2020
Q2 		$531K Sell
17,104
-929
-5% -$31.6K 0.26% 76
2020
Q1 		$558K Buy
18,033
+1,089
+6% +$37.1K 0.38% 71
2019
Q4 		$630K Sell
16,944
-220
-1% -$7.84K 0.35% 69
2019
Q3 		$585K Buy
+17,164
New +$624K 0.35% 71
2019
Q1 		$671K Buy
+16,665
New +$667K 0.51% 58

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TAP Consulting's PFE Position: Q4 2024 in Review

TAP Consulting sold out of Pfizer (PFE) in Q4 2024, closing a stake of 8,734 shares — an estimated $253K sold.

TAP Consulting first reported a position in PFE in Q1 2019 and held it in 22 quarters. The position peaked at $1.27M in Q4 2021. 3,001 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • TAP Consulting reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • TAP Consulting sold 8,734 Pfizer shares in Q4 2024, an estimated $253K.
  • TAP Consulting first reported a position in Pfizer in Q1 2019 and held it in 22 quarters.
  • TAP Consulting's Pfizer position peaked at $1.27M in Q4 2021.
  • 3,001 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on TAP Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.